Pharmaceutical News and Articles

California Reports Two Cases of Bird Flu in Dairy Workers, a First for the State

As an outbreak of bird flu among dairy cows continues to spread in the United States, two more cases have been reported in dairy workers, this time in Californi

Water Fluoridation May Be Less Beneficial Than in Past, Review Finds

The health benefits of fluoridated drinking water may be waning as Americans increasingly turn to using toothpastes and mouthwashes that already contain fluorid

Fatal Falls After Age 45 Years Cost More Than Fatal Firearm Injuries

Fatal falls incur significantly higher costs than fatal firearm injuries among those aged older than 45 years, according to a study published online Oct. 1 in T

CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable Danger

from all 50 states, the U.S. Virgin Islands, Puerto Rico, Germany, and Slovenia, the U.S. Department of Justice said in a statement announcing the indictment. A

2017 to 2021 Saw Increase in Clinically Diagnosed Depression in Youth

Clinically diagnosed depression increased from 2017 to 2021 in children, adolescents, and young adults, with a higher increase during the pandemic, according to

Incident Stroke Tied to Acute, Accelerated Long-Term Cognitive Decline

For older stroke survivors, incident stroke is associated with acute and accelerated long-term cognitive decline, according to a study published online Oct. 2 i

Gilead Signs Royalty-Free Voluntary Licensing Agreements with Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries

Foster City, Calif. October 2, 2024 Gilead Sciences, Inc. (Nasdaq GILD) today announced that it has signed non-exclusive, royalty-free voluntary licensing agree

Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

NEW HAVEN, Conn., Oct. 3, 2024. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbup

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis